Key Market Indicator:
F&G: 63
25.251,30 NASDAQ · 49.087,99 DOW · 6.888,45 S&P · 4.663,17 Gold · 63,09 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
© Globe Newswire
20.08.2025
ISIN: DK0060336014

Novozymes A/S
NSIS B

LISTED

CPH
2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement
News Preview
Novonesis today announces its ‘GROW’ strategy and long-term targets for the strategy period until 2030 focusing on an acceleration of the core business and significant re-investments to secure long-term growth. By 2030, the company expects to deliver an organic sales CAGR of 6-9%, an adjusted EBITDA margin of ~39% and an adjusted ROIC excl. goodwil...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
ISIN: IE000LK2BOB4

Mural Oncology PLC
MURA

LISTED

NASDAQ
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
News Preview
WALTHAM, Mass., DUBLIN, Ireland and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company (“Mural”), and XOMA Royalty Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator (“XOMA Royalty”), announced today they have entered into a definitive agreement pursuant to...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
ISIN: US4577301090

Inspire Medical Systems Inc
INSP

LISTED

NYSE
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference
News Preview
MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 2025 Heal...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar

USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
20.08.2025
ISIN: FI0009014377

Orion Oyj
ORNBV

LISTED

HEL
337,000 Orion Corporation A shares converted into B shares
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 20 AUGUST 2025 at 9.00 EEST        ...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
20.08.2025
ISIN: BE0003766806

Ion Beam Applications SA
IBAB

LISTED

EURONEXT
Heidelberg University Hospital expands its particle therapy program with IBA’s Proteus®ONE solution
News Preview
Louvain-La-Neuve, Belgium, August 20, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer and Heidelberg University Hospital (Universitätsklinikum Heidelberg AöR, UKHD) announce today that they have signed a co...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US5588681057

Madrigal Pharmaceuticals Inc
MDGL

LISTED

NASDAQ
Madrigal Receives European Commission Approval for Rezdiffra™ (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
News Preview
CONSHOHOCKEN, Pa., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that the European Commission (EC) has granted conditional marketing authorization for Rezdiffra (resme...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US67079U3068

Nutex Health Inc
NUTX

LISTED

NASDAQ
Securities Fraud Investigation Into Nutex Health Inc. (NUTX) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUTEX HEALTH INC. (NUTX), CLICK HERE...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: DK0060448595

Coloplast A/S
COLO B

LISTED

CPH
Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025
News Preview
Following the changes to the Executive Leadership Team, announced on 19.08.2025*, we are pleased to share with you the updated presenters list for our Capital Markets Day on 2 September 2025. For those of you who have signed up, we look forward to seeing you at the event. ...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US98887Q1040

Zai Lab Limited
ZLAB

LISTED

NASDAQ
Zai Lab Announces China National Medical Products Administration Grants Innovative Medical Device Designation for Tumor Treating Fields for Patients with Pancreatic Cancer
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the China National Medical Products Administration (NMPA) has granted Innovative Medical Device Designation for Tumor Treating Fields (TTFields) for patients with pancreatic cancer based on the positive results from the Phase 3 PANOVA-3 trial. The Innovative Medical Device Designation...
Themefolio
Profiler
Peergroup
© EQS Newswire
19.08.2025
ISIN: FR0004056851

Valneva SE
VLA

LISTED

EURONEXT
First Berlin Equity Research GmbH: Valneva SE | Rating: Buy
News Preview
Original-Research: Valneva SE - from First Berlin Equity Research GmbH 19.08.2025 / 10:39 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain......
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US8793691069

Teleflex Inc
TFX

LISTED

NYSE
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
News Preview
Innovative hyaluronic acid technology delivers enhanced control and precision, significantly lowering the risk of rectal toxicity during prostate radiation treatment.1-4Initial cases have now been performed in Japan....
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: DK0060448595

Coloplast A/S
COLO B

LISTED

CPH
Coloplast A/S - Interim Financial Report, 9M 2024/25
News Preview
2024/25...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
19.08.2025
ISIN: DK0060448595

Coloplast A/S
COLO B

LISTED

CPH
Coloplast A/S - Announcement no. 05/2025 - Coloplast announces changes to Executive Leadership Team
News Preview
Coloplast announces changes to Executive Leadership Team...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: US67079U3068

Nutex Health Inc
NUTX

LISTED

NASDAQ
Nutex Health Inc. (NUTX) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith continues its investigation on behalf of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN NUTEX HEALTH INC. (NUTX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: US67079U3068

Nutex Health Inc
NUTX

LISTED

NASDAQ
Securities Fraud Investigation Into Nutex Health Inc. (NUTX) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz continues its investigation of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUTEX HEALTH INC. (NUTX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: GB00BYMT0J19

LivaNova PLC
LIVN

LISTED

NASDAQ
LivaNova Launches Essenz Perfusion System in China
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it initiated the commercial launch of the Essenz™ Perfusion System in China, the second-largest market for LivaNova heart-lung machines (HLMs) after the United States. The Essenz Perfusion System, which recently received regulatory approval from China’s Natio...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: DE000BAY0017

Bayer AG
BAYN

LISTED

XETR
Monsanto Reaches Agreements in Principle to Resolve Additional PCB Cases at the Sky Valley Education Center
News Preview
Monsanto has now reached agreements in principle to resolve all Sky Valley Education Center cases, representing more than 200 plaintiffs overall, with the exception of the prior adverse verdicts that remain on appeal. The Sky Valley Education Center cases involve allegations of injuries due to exposure to polychlorinated biphenyls (PCBs) at the sc...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US52490G1022

Legend Biotech Corp
LEGN

LISTED

NASDAQ
Legend Biotech Appoints Carlos Santos as Chief Financial Officer
News Preview
SOMERSET, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Carlos Santos as the Company’s Chief Financial Officer, effective immediately. Mr. Santos assumes the role from Jessie Yeung, who has served as the interim CFO since Janu...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US68232V8019

Traws Pharma Inc.
TRAW

LISTED

NASDAQ
Traws Pharma Receives Approval to Proceed with Phase 2 COVID Studies with Ratutrelvir, Expects Results by Year-End 2025
News Preview
Non-inferiority trial to assess safety and efficacy, including rates of disease rebound and incidence of Long COVID development of ratutrelvir, a ritonavir-free treatment, compared to PAXLOVID®...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: SE0022419784

Sectra AB
SECT_B

LISTED

STO
6 Canadian healthcare providers to consolidate imaging with Sectra's cloud-based enterprise imaging solution for enhanced patient care
News Preview
LINKÖPING, Sweden and MISSISSAUGA, ON, Aug. 18, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will enable six of the Canadian ENHANCE Ontario's (Enabling Healthcare Across Networks of Central East Ontario) member hospitals to consolidate their imaging across 13 hospital sites with its cloud-b...
Themefolio
Profiler
Peergroup
© BusinessWire
15.08.2025
ISIN: US67079U3068

Nutex Health Inc
NUTX

LISTED

NASDAQ
NUTX Investors Have Opportunity to Join Nutex Health Inc. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disc...
Themefolio
Profiler
Peergroup
© BusinessWire
15.08.2025
ISIN: DE000BAY0017

Bayer AG
BAYN

LISTED

XETR
Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market
News Preview
Bayer’s Aspirina, the #1 pain relief option in Mexico1, is now available for purchase in the United States, bringing a well-known brand to the Hispanic community. With a deep commitment to Hispanic consumers, Aspirina is poised to provide an accessible and effective solution for pain relief. As the Hispanic population in the U.S. continues to gr...
Themefolio
Profiler
Peergroup
© PR Newswire
14.08.2025
ISIN: US67079U3068

Nutex Health Inc
NUTX

LISTED

NASDAQ
NUTEX HEALTH PROVIDES PRELIMINARY SECOND QUARTER FINANCIAL RESULTS, ANNOUNCES DELAY IN FILING ITS 2025 SECOND QUARTER FINANCIAL STATEMENTS AND ANNOUNCES A STOCK REPURCHASE PROGRAM OF UP TO $25 MILLION
News Preview
HOUSTON, Aug. 14, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will...
Themefolio
Profiler
Peergroup
© BusinessWire
14.08.2025
ISIN: US4577301090

Inspire Medical Systems Inc
INSP

LISTED

NYSE
NYSE: INSP Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Inspire Medical Systems, Inc. (NYSE: INSP) Investors With Significant Losses to Contact the Firm
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”). On August 4, 2025, Inspire issued a press release announcing its second quarter financial results and updating its 2...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.08.2025
ISIN: NL0015000DX5

Atai Life Sciences N.V.
ATAI

LISTED

NASDAQ
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
News Preview
Planned strategic combination with Beckley Psytech expected to solidify position as global leader in transformative, psychedelic-based mental health therapies with a short time in-clinic...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.08.2025
ISIN: US68232V8019

Traws Pharma Inc.
TRAW

LISTED

NASDAQ
Traws Pharma Reports Second Quarter 2025 Results and Business Highlights
News Preview
Advancing novel programs for respiratory viruses that pose pandemic threats or risk of serious illness, including SARS CoV2 (ratutrelvir) and influenza (Tivoxavir marboxil, TXM)...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.08.2025
ISIN: US74039M3097

Predictive Oncology, Inc.
POAI

LISTED

NASDAQ
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
News Preview
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.08.2025
ISIN: DK0060257814

Zealand Pharma A/S
ZEAL

LISTED

CPH
Zealand Pharma Announces Financial Results for the First Half of 2025
News Preview
Company announcement – No. 18 / 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
13.08.2025
ISIN: US98887Q1040

Zai Lab Limited
ZLAB

LISTED

NASDAQ
Zai Lab Establishes Oncology Scientific Advisory Board
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the creation of its Oncology Scientific Advisory Board (SAB). The newly formed Oncology SAB is comprised of distinguished oncology leaders and will support the advancement of the Company’s robust oncology products and pipeline, including multiple internally developed investigational therap...
Themefolio
Profiler
Peergroup
© PR Newswire
13.08.2025
ISIN: SE0009807266

Integrum AB (B)
INTEG B

LISTED

STO
Integrum secures top sponsorship title at the Global Collaborative Congress on Osseointegration exclusively for the next three years
News Preview
MÖLNDAL, Sweden, Aug. 13, 2025 /PRNewswire/ -- Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), the provider of the OPRA™ Implant System, has announced that it has secured the exclusive title of Legacy Sponsor - the highest level of sponsorship - for the Global Collaborative Congress on Osseointegration (GCCO) annual meeting, held...
Themefolio
Profiler
Peergroup
© BusinessWire
13.08.2025
ISIN: CA68617J1003

Organigram Global Inc
OGI

LISTED

NASDAQ
Organigram Reports Record Third Quarter Fiscal 2025 Results
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, is pleased to announce its record results for the third quarter ended June 30, 2025 (“Q3 Fiscal 2025” or “Q3”). Q3 FISCAL 2025 HIGHLIGHTS Record Gross Revenue: $110.2 million (+73% year-over-year, +7.2% sequential)....
Themefolio
Profiler
Peergroup
© Globe Newswire
13.08.2025
ISIN: US45783C2008

Instil Bio Inc
TIL

LISTED

NASDAQ
Instil Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update
News Preview
With the clearance of the U.S. IND, initiation of the U.S. clinical trial of AXN-2510/IMM2510 (“‘2510”) anticipated before the end of 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
13.08.2025
ISIN: SE0022419784

Sectra AB
SECT_B

LISTED

STO
Sectra's new security attestation lowers barrier for healthcare providers to adopt cloud services in Germany
News Preview
LINKÖPING, Sweden, Aug. 13, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has received the security attestation Cloud Computing Compliance Criteria Catalogue (C5) for its Software-as-a-Service (SaaS) for enterprise imaging, Sectra One Cloud. With Sectra being one of the first in the field in...
Themefolio
Profiler
Peergroup
© EQS Newswire
13.08.2025
ISIN: DE000A1MMCC8

Medios AG
ILM1

LISTED

XETR
Medios accelerates growth in the first half of 2025 and significantly increases earnings
News Preview
Press release Medios accelerates growth in the first half of 2025 and significantly increases earnings Revenue up 9.3% to €991.7 million EBITDA pre1 up by a disproportionate 48.8% Organic EBITDA pre1 growth of 12.3% Earnings per share almost doubled to €0.50 Successful public share buyback offer Outlook for 2025 confirmed: Further increase i......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.08.2025
ISIN: DE000A1MMCC8

Medios AG
ILM1

LISTED

XETR
Medios beschleunigt Wachstum im ersten Halbjahr 2025 und steigert Ergebnis deutlich
News Preview
Pressemitteilung Medios beschleunigt Wachstum im ersten Halbjahr 2025 und steigert Ergebnis deutlich Umsatzsteigerung um 9,3 % auf 991,7 Mio. € Überproportionaler Anstieg des EBITDA pre1 um 48,8 % Organisches EBITDA-pre1-Wachstum von 12,3 % Ergebnis je Aktie auf 0,50 € nahezu verdoppelt Erfolgreiches öffentliches Aktienrückkaufangebot Ausbl......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.08.2025
ISIN: DE0005664809

Evotec SE
EVT

LISTED

XETR
Deutliche Fortschritte bei Strategieumsetzung
News Preview
Strategie für nachhaltiges profitables Wachstum verläuft planmäßig mit Verbesserung des Umsatzmixes und über dem Plan liegenden Kostensenkungen Das bisher als „Shared R&D” bezeichnete Berichtssegment wurde in „Discovery & Preclinical Development” („D&PD“) umbenannt, um den strategischen Fokus besser widerzuspiegeln Konzernumsatz......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.08.2025
ISIN: DE0005664809

Evotec SE
EVT

LISTED

XETR
Strong progress on strategy execution
News Preview
  Strategy for sustainable profitable growth progressing as planned with improving revenue mix and ahead-of-plan cost reductions Reporting segment formerly known as Shared R&D renamed to Discovery & Preclinical Development (“D&PD”) to better reflect strategic focus Group revenues of € 371.2 m (-5%); D&PD (-11%) continu......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.08.2025
ISIN: DE000A1EWVY8

Formycon AG
FYB

LISTED

XETR
Formycon confirms full-year guidance following business development in line with plan – working capital raised
News Preview
Press Release // August 13, 2025   Formycon confirms full-year guidance following business development in line with plan – working capital raised Half-year results in line with expectations – full-year 2025 guidance confirmed Outlook for working capital raised following successful placement of oversubscribed €70 million corporate bond Strong se......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.08.2025
ISIN: DE000A1EWVY8

Formycon AG
FYB

LISTED

XETR
Formycon bestätigt Jahresprognose nach planmäßiger Geschäftsentwicklung und hebt Working Capital an
News Preview
Pressemitteilung // 13. August 2025   Formycon bestätigt Jahresprognose nach planmäßiger Geschäftsentwicklung und hebt Working Capital an Halbjahreszahlen im Rahmen der Erwartungen – Prognose für das Geschäftsjahr 2025 bestätigt Prognostiziertes Working Capital aufgrund erfolgreicher Platzierung einer überzeichneten 70 Mio. € Unternehmensanleihe......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.08.2025
ISIN: DE0005664809

Evotec SE
EVT

LISTED

XETR
Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution
News Preview
Strategy for sustainable profitable growth progressing as planned with improving revenue mix and ahead-of-plan cost reductionsReporting segment formerly known as Shared R&D renamed to Discovery & Preclinical Development ("D&PD") to better reflect strategic focusGroup revenues of € 371.2 m (-5%); D&PD (-11%) continues...
Themefolio
Profiler
Peergroup
© PR Newswire
12.08.2025
ISIN: US17322U3068

Citius Pharmaceuticals Inc
CTXR

LISTED

NASDAQ
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update
News Preview
$12.5 million in gross financings raised during the quarter, with an additional $9 million raised by Citius Oncology in July 2025, to facilitate LYMPHIR pre-launch initiatives and drive successful market introduction CRANFORD, N.J., Aug. 12, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a la...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.08.2025
ISIN: DK0010272202

Genmab A/S
GMAB

LISTED

CPH
Capital Increase in Genmab as a Result of Employee Warrant Exercise
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.08.2025
ISIN: FR0012127173

OSE Immunotherapeutics SA
OSE

LISTED

EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
News Preview
Informations relatives au nombre total de droits de vote et d’actions composant le capital...
Themefolio
Profiler
Peergroup
© PR Newswire
12.08.2025
ISIN: CA05156X8504

Aurora Cannabis Inc
ACB

LISTED

NASDAQ
Aurora Ignites Global Expansion with Whistler Cannabis Co. Brand Debut in Australia
News Preview
Canada's Largest Medical Cannabis Company to Launch Two High-Potency Cultivars, Expanding Patient Choice in Australia EDMONTON, ALBERTA, Aug. 12, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the launch of Whistler Cannabis Co. in Australia. As one of Canad...
Themefolio
Profiler
Peergroup
© PR Newswire
12.08.2025
ISIN: CA05156X8504

Aurora Cannabis Inc
ACB

LISTED

NASDAQ
Aurora Ignites Global Expansion with Whistler Cannabis Co. Brand Debut in Australia
News Preview
Canada's Largest Medical Cannabis Company to Launch Two High-Potency Cultivars, Expanding Patient Choice in Australia EDMONTON, ALBERTA, Aug. 12, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the launch of Whistler Cannabis Co. in Australia. As one of Canada's ori...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.08.2025
ISIN: US05280R1005

Autolus Therapeutics plc
AUTL

LISTED

NASDAQ
Autolus Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates
News Preview
Autolus announced its operational and financial results for the second quarter ended June 30, 2025....
Themefolio
Profiler
Peergroup
© EQS Newswire
12.08.2025
ISIN: DE000A0LD6E6

Gerresheimer AG
GXI

LISTED

XETR
Achim Schalk To Join the Gerresheimer Management Board
News Preview
Achim Schalk To Join the Gerresheimer Management Board Experienced industrial manager to succeed Dr. Lukas Burkhardt on November 1, 2025 Responsibility for the Moulded Glass, Tubular Glass, and Syringe Systems business units  Düsseldorf, August 12, 2025. The Supervisory Board of Gerresheimer AG has appointed Achim Schalk to the Management Board ......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.08.2025
ISIN: DE000A0LD6E6

Gerresheimer AG
GXI

LISTED

XETR
Achim Schalk wird Vorstand bei Gerresheimer
News Preview
Achim Schalk wird Vorstand bei Gerresheimer Erfahrener Industriemanager tritt zum 1. November 2025 Nachfolge von Dr. Lukas Burkhardt an Verantwortung für die Business Units Moulded Glass, Tubular Glass und Syringe Systems Düsseldorf, 12. August 2025. Der Aufsichtsrat der Gerresheimer AG hat Achim Schalk zum Vorstand der Unternehmensgruppe bestell......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.08.2025
ISIN: CH0012549785

Sonova Holding AG
SOON

LISTED

SIX
Sonova erweitert die Infinio-Reihe und steigt mit dem kleinsten und ersten wiederaufladbaren Im-Ohr-Hörgerät von Phonak in ein neues Marktsegment ein
News Preview
Sonova Holding AG / Schlagwort(e): Produkteinführung Sonova erweitert die Infinio-Reihe und steigt mit dem kleinsten und ersten wiederaufladbaren Im-Ohr-Hörgerät von Phonak in ein neues Marktsegment ein 12.08.2025 / 07:00 CET/CEST Group Media & Investor Release Stäfa (Schweiz), 12. August 2025 – Mit dem massgefertig......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.08.2025
ISIN: CH0012549785

Sonova Holding AG
SOON

LISTED

SIX
Sonova expands Infinio range and enters new market segment with Phonak’s smallest and first rechargeable in-the-ear hearing aid
News Preview
Sonova Holding AG / Key word(s): Product Launch Sonova expands Infinio range and enters new market segment with Phonak’s smallest and first rechargeable in-the-ear hearing aid 12.08.2025 / 07:00 CET/CEST Group Media & Investor Release Staefa (Switzerland), August 12, 2025 – With Phonak Virto R Infinio, Sonova introd......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.08.2025
ISIN: DE000A3ENQ51

SCHOTT Pharma AG & Co KgaA
1SXP

LISTED

XETR
SCHOTT Pharma erzielt solide finale Ergebnisse im dritten Quartal
News Preview
SCHOTT Pharma erzielt solide finale Ergebnisse im dritten Quartal Umsatz in Q3 2025 um 1 % auf 256 Mio. Euro gestiegen; währungsbereinigtes Wachstum von 3 % gegenüber dem Vorjahr EBITDA-Marge in Q3 2025 berichtet bei 32,4 % und währungsbereinigt bei 31,7 % Anteil margenstarker High-Value-Lösungen (HVS) in Q3 2025 bei 60 % Prognose für organisch......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.08.2025
ISIN: DE000A3ENQ51

SCHOTT Pharma AG & Co KgaA
1SXP

LISTED

XETR
SCHOTT Pharma delivers solid final third-quarter results
News Preview
SCHOTT Pharma delivers solid final third-quarter results Q3 2025 revenues up 1% yoy to EUR 256m; increase of 3% yoy at constant currencies Q3 2025 EBITDA margin of 32.4% as reported and 31.7% at constant currencies Share of strong-margin high-value solutions (HVS) at 60% in Q3 2025 Organic revenue growth for FY 2025 is expected to be around 6.......
Themefolio
Profiler
Peergroup
© Globe Newswire
12.08.2025
ISIN: DK0010272632

GN Store Nord A/S
GN

LISTED

CPH
GN introduces ReSound Enzo IA: Exceptional speech understanding and all-day battery life – in the world’s smallest rechargeable Super Power hearing aid
News Preview
BALLERUP, Denmark, Aug. 12, 2025 (GLOBE NEWSWIRE) -- GN, a global leader in hearing technology, announced today the launch of ReSound Enzo™ IA, the world's smallest rechargeable Super Power hearing aid,1 representing a huge leap forward in sound quality for people with severe to profound hearing loss....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.08.2025
ISIN: US4577301090

Inspire Medical Systems Inc
INSP

LISTED

NYSE
Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program
News Preview
MINNEAPOLIS, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that its Board of Directors has authorized t...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.08.2025
ISIN: US5588681057

Madrigal Pharmaceuticals Inc
MDGL

LISTED

NASDAQ
Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference
News Preview
CONSHOHOCKEN, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the Canaccord Genuity 45th Annual Growth Conference on Tuesday, Aug. 12, 2025 at 10:30 A.M. EDT....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.08.2025
ISIN: US52490G1022

Legend Biotech Corp
LEGN

LISTED

NASDAQ
Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights
News Preview
SOMERSET, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its second quarter 2025 unaudited financial results and key corporate highlights....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.08.2025
ISIN: US68232V8019

Traws Pharma Inc.
TRAW

LISTED

NASDAQ
Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
News Preview
NEWTOWN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral diseases, today announced plans to host a conference call and webcast on Thursday, Aug...
Themefolio
Profiler
Peergroup
© PR Newswire
08.08.2025
ISIN: SE0000135485

RaySearch Laboratories AB (publ)
RAY B

LISTED

STO
RaySearch Laboratories: Interim report April - June 2025
News Preview
STOCKHOLM, Aug. 8, 2025 /PRNewswire/ -- SECOND QUARTER (APRIL - JUNE 2025) Order intake amounted to SEK 241.2 M (290.3)Net sales amounted to SEK 304.9 (318.9)Operating profit amounted to SEK 36.4 M (79.3)Profit after tax amounted to SEK 30.8 M (61.4)Earnings per share before/after dilution amounted to SEK 0.90 (1.79) Cash flow from operating act...
Themefolio
Profiler
Peergroup
© EQS Newswire
08.08.2025
ISIN: DE0005659700

Eckert & Ziegler SE
EUZ

LISTED

XETR
Further Increase in Earnings in the First Half of 2025
News Preview
2nd Quarter 2025: Sales: € 80.6 Mio. million (PY: € 77.8 million) EBIT before special items: € 19.2 million (PY: € 17.5 million) Net income: € 11,7 million (PY: € 9.5 million) 1st Half Year 2025: Sales: € 148.8 million (PY: € 145.4 million) EBIT before special items: € 35.4 million (PY: € 32.5 million) Net income: € 21.4 million (PY: € 18.0 m......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.08.2025
ISIN: DE0005659700

Eckert & Ziegler SE
EUZ

LISTED

XETR
Erneute Ergebnissteigerung im ersten Halbjahr 2025
News Preview
2. Quartal 2025: Umsatz: 80,6 Mio. € (VJ: 77,8 Mio. €) EBIT vor Sondereinflüssen: 19,2 Mio. € (VJ: 17,5 Mio. €) Nettogewinn: 11,7 Mio. € (VJ: 9,5 Mio. €) 1. Halbjahr 2025: Umsatz: 148,8 Mio. € (VJ: 145,4 Mio. €) EBIT vor Sondereinflüssen: 35,4 Mio. € (VJ: 32,5 Mio. €) Nettogewinn: 21,4 Mio. € (VJ: 18,0 Mio. €) Jahresprognose 2025: Umsatz vo......
Themefolio
Profiler
Peergroup

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2026 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 19.01.2026, Calendar Week 04, 19th day of the year, 346 days remaining until EoY.